A humanized yeast proteasome identifies unique binding modes of inhibitors for the immunosubunit beta 5i.
Huber, E.M., Heinemeyer, W., de Bruin, G., Overkleeft, H.S., Groll, M.(2016) EMBO J. 35: 2602-2613
- PubMed: 27789522 
- DOI: 10.15252/embj.201695222
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Inhibition of the immunoproteasome subunit β5i alleviates autoimmune diseases in preclinical studies and represents a promising new anti-inflammatory therapy. However, the lack of structural data on the human immunoproteasome still hampers drug desig ...